Spirulina Supplementation and Infant Growth, Morbidity and Motor Development
Promoting Spirulina Production and Utilization in Luapula Province of Zambia
1 other identifier
interventional
501
1 country
1
Brief Summary
Background: In developing countries, micronutrient deficiency in infants is associated with growth faltering, morbidity, and delayed motor development. One of the potentially low-cost and sustainable solutions is to use locally producible food for the home fortification of complementary foods. Objective: The objectives are to test the hypothesis that locally producible spirulina platensis supplementation would achieve the following: 1) increase infant physical growth; 2) reduce morbidity; and 3) improve motor development. Design: 501 Zambian infants are randomly assigned into a control (CON) group or a spirulina (SP) group. Children in the CON group (n=250) receive a soya-maize-based porridge for 12 months, whereas those in the SP group (n=251) receive the same food but with the addition of spirulina. The change in infants' anthropometric status, morbidity, and motor development over 12 months are assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2018
CompletedFirst Submitted
Initial submission to the registry
April 19, 2018
CompletedFirst Posted
Study publicly available on registry
May 14, 2018
CompletedFebruary 11, 2019
February 1, 2019
1.2 years
April 19, 2018
February 7, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from baseline in height-for-age z-scores (HAZ) at 32 month follow up
Primary outcome is changes in HAZ. Height of the infants is transformed to standardized scores using the World Health Organization (WHO) Multicentre Growth Standards
Height of the infants are measured by experienced field workers at at 0, 6, and 12 month. Amendment: also measured at extension endline (October 2016), at 24 month follow up (April 2017) and at 32 month follow up (January 2018) survey.
Child development
Study children will be assessed at 32 month follow up (January 2018) using the Malawi Development Assessment Tool (MDAT) instrument. Scores will be standardized within the study sample for analysis. Scores of children in treatment group will be compared with children in comparison group to determine differences.
At 32 month follow up (January 2018) survey
Secondary Outcomes (7)
Change from baseline in weight-for-age z-scores (WAZ) at 32 month follow up
Weight of the infants are measured at 0, 6, and 12 month by experienced field workers. Amendment: also measured at extension endline (October 2016), at 24 month follow up (April 2017) and at 32 month follow up (January 2018)
Change from baseline in pneumonia incidence at 32 month follow up
Data on pneumonia indicators were collected up to 12 months by trained local health workers. Amendment: also measured at extension endline (October 2016), at 24 month follow up (April 2017) and at 32 month follow up (January 2018)
Change from baseline in cough incidence at 32 month follow up
Data on cough morbidity indicators are collected up to 12 months by trained local health workers. Amendment: also measured at extension endline (October 2016), at 24 month follow up (April 2017) and at 32 month follow up (January 2018)
Change from baseline in severe high fever incidence at 32 month follow up
Data are collected up to 12 months by trained local health workers. Amendment: also measured at extension endline (October 2016), at 24 month follow up (April 2017) and at 32 month follow up (January 2018)
Change from baseline in fever incidence at 32 month follow up
Data are collected up to 12 months by trained local health workers. Amendment: also measured at extension endline (October 2016), at 24 month follow up (April 2017) and at 32 month follow up (January 2018)
- +2 more secondary outcomes
Study Arms (2)
Spirulina (SP)
EXPERIMENTALChildren in the SP group (n=251) received a soya-maize-based porridge for 12 months with the addition of spirulina.
Control (CON)
ACTIVE COMPARATORChildren in the CON group (n=250) received a soya-maize-based porridge for 12 months.
Interventions
Arthrospira platensis, also known as spirulina, is a blue-green micro-algae indigenous to Africa. Spirulina group (n=251) receive a soya-maize-based porridge with the addition of spirulina. We used 10 g per day of spirulina powder with a mealie meal and soya flour porridge blend.
Children receive a soya-maize-based porridge for 12 months. We use a mealie meal and soya flour porridge blend.
Eligibility Criteria
You may qualify if:
- All infants were eligible for the study if they are between 6 and 18 month of age
You may not qualify if:
- Non-singleton birth infants were excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Programme Against Malnutritionlead
- Hitotsubashi Universitycollaborator
- Alliance Forum Foundationcollaborator
Study Sites (1)
Programme Against Malnutrition
Mansa, Luapura, Zambia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kazuya Masuda, PhD
Hitotsubashi University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 19, 2018
First Posted
May 14, 2018
Study Start
March 1, 2015
Primary Completion
April 30, 2016
Study Completion
January 30, 2018
Last Updated
February 11, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share